medicines promotion

News

Novo Nordisk returns to ABPI fold after two-year suspension

Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."

News

AZ, Leo, and Daiichi Sankyo rapped for ad transgressions

Leo Pharma, AstraZeneca, and Daiichi Sankyo are the latest drugmakers to fall foul of UK guidelines on advertising of medicines.

News

Novo Nordisk suspended from ABPI after code breach

The two-year ban reflects "serious breaches” of the trade organisation’s code of practice.

News

Hilversum, The Netherlands - April 03, 2014. Image of a touch screen Android phone with social media apps.

ABPI code updated with first social media guidance

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time.

Views & Analysis

New IFPMA and EFPIA guidance on use of social media by the p...

On 28 September 2022, the international and European self-regulatory bodies for the research-based pharmaceutical industry (I

Novo Nordisk returns to ABPI fold after two-year suspension

AZ, Leo, and Daiichi Sankyo rapped for ad transgressions

Novo Nordisk suspended from ABPI after code breach

ABPI code updated with first social media guidance

New IFPMA and EFPIA guidance on use of social media by the p...

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

medicines promotion

Editor's Picks